ISMP Newsroom

Safe medication practices depend on communication within the healthcare community, including patients and their families. ISMP is at the forefront of medication error reporting and guidance on safe medication practices, and is often cited in the media as a reputable resource for current information and emerging trends. In 2020, ISMP formally affiliated with ECRI to create one of the largest quality and safety entities in the world. ISMP's Newsroom includes ISMP and ECRI news releases, as well as ISMP blog posts, statements, and other communications. 

To schedule an interview or request to be added to ISMP’s news release distribution lists, contact Renee Brehio.

Recent Updates

Filter by type
Wolters Kluwer has issued a correction for the Methylprednisolone Acetate Injection monograph in the Drug Facts & Comparisons database and in the print publication Drug Facts and Comparisons-- 2015 and 2016.
This QuarterWatch™ annual report issue identifies sodium-glucose cotransporter-2 (SGLT2) inhibitor drugs for type 2 diabetes as ranking among the top safety concerns of the year.
Caffeine powder is marketed as a “pick-me-up”, and young people and athletes sometimes use it to make inexpensive, homemade caffeinated drinks and foods. But use of this powder can result in serious harm, including death.
In 2016, ISMP celebrated two decades of publishing the ISMP Medication Safety Alert!® newsletter, the nation’s only publication reaching nearly every U.S. hospital with vital and potentially lifesaving information on medication and device errors.
Report from 2014 Summit Explores Factors Causing Shortages to Persist As shortages of lifesaving medicines, including antibiotics, chemotherapy, and cardiovascular drugs continue to plague the United States, a group of health care organizations released a report exploring measures that should be